Medicinal chemistry and nanomedicine for reproductive cancer therapeutics.
Nanomedicine is an interdisciplinary research field where chemistry, physics, biology, engineering, nanotechnology, and medicine meet one other. Many novel nanoparticles have been designed, synthesized, and evaluated for selective targeting of cancer cells, delivering, and releasing the anticancer drugs in a controlled manner. In this review article we discuss the current status and future prospects of medicinal chemistry of nanomedicine with particular attention to nanoparticle systems that are in various stages of development for cancer therapy in reproductive medicine.
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Emory University, Atlanta, GA 30322, USA. majumdar.debatosh@gmail.com
Debatosh
D
Majumdar
Sunil
S
Singhal
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004337:Drug Carriers; D006801:Humans; D050997:Nanomedicine; D009369:Neoplasms / Q000188:drug therapy*; D018456:Reproductive Medicine
D000970:Antineoplastic Agents; D004337:Drug Carriers